SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$69.52
−0.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 246.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.73x
- Price / sales
- 126.80x
- Price / cash flow
- 706.86x
Enterprise value
- Enterprise value
- $180.4M
- EV / sales
- 100.53x
- EV / EBITDA
- -10.39x
- EV / EBIT
- -10.19x
- Market cap
- $227.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026